Dianthus Therapeutics Inc (DNTH) Gross Profit Margin starting from the third quarter 2026 to third quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Dianthus Therapeutics Inc   (NASDAQ: DNTH)


Dianthus Therapeutics Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics



DNTH Gross Profit Margin (Sep 30 2026)
Q3
(Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
Y / Y Revenue Change 205.56 %
Seq. Revenue Change 59 %
Revenue In Millions $1.21
Gross Profit Margin 0 %
Gross Profit Margin Total Ranking # 783
Gross Profit In Millions $0.00
Y / Y Gross Profit Change -
Seq. Gross Profit Change -


Commenting Third Quarter 2026 Gross Profit Margin



Observing third quarter 2026 results within Major Pharmaceutical Preparations industry 104 other companies have achieved higher Gross Profit Margin. While overall Gross Profit Margin ranking remained unchanged compared to the previous quarter at no. .
Learn about Gross Margin
DNTH's Gross Profit Margin third quarter 2026 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 105
Healthcare Sector # 178
Overall # 783

Gross Profit Margin Statistics
High Average Low
100 % 100 % 100 %
(Dec 31 2025)  




Other Gross Profit Margin Profitability Ratios
DNTH's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
DNTH's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for DNTH's Competitors
Gross Profit Margin Profit Margin for Dianthus Therapeutics Inc 's Suppliers
Gross Profit Margin Profit Margin for DNTH's Customers

You may also want to know
DNTH's Annual Growth Rates DNTH's Profitability Ratios DNTH's Asset Turnover Ratio DNTH's Dividend Growth
DNTH's Roe DNTH's Valuation Ratios DNTH's Financial Strength Ratios DNTH's Gross Profit Growth
DNTH's Roa DNTH's Inventory Turnover Ratio DNTH's Growth Rates DNTH's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 30 2026, within Major Pharmaceutical Preparations Industry Gross Profit MarginSep 30 2026 MRQ Gross ProfitSep 30 2026 MRQ Revenue




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.